Replies to post #160386 on Biotech Values

[genisi]

RCPT

Is RCPT's drug primarily just limited to potentially improving upon the safety of Gilenya or is there the potential for it to improve upon efficacy as well? Ideally, I'd hope there be potential for improvements in both.

I think better efficacy is not on the menu and that they would be happy with improved safety profile without losing Gilenya like efficacy. That goes for all next gen S1PR agonists players.